Generic Pharmasec Ltd.
BSE: 531592 | Sector: Industrials |
NSE: N.A. | ISIN Code: INE861N01036 |
BSE 00:00 | 08 Mar | 8.86 |
-0.03 (-0.34%) |
OPEN
9.12 |
HIGH
9.12 |
LOW
8.67 |
NSE 05:30 | 01 Jan | Generic Pharmasec Ltd |
OPEN | 9.12 |
PREVIOUS CLOSE | 8.89 |
VOLUME | 168026 |
52-Week high | 16.63 |
52-Week low | 8.50 |
P/E | 221.50 |
Mkt Cap.(Rs cr) | 245 |
Buy Price | 8.70 |
Buy Qty | 2010.00 |
Sell Price | 8.80 |
Sell Qty | 2865.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Generic Pharmasec Ltd. (GENERICPHARMA) - Balance Sheet
Figures in Rs crore | 2020 | 2019 | 2018 |
Sources of Funds | |||
Share Capital | 21.69 | 21.69 | 0.33 |
Reserves | -2.65 | -0.07 | -1.19 |
Total Shareholders Funds | 19.04 | 21.62 | -0.86 |
Secured Loans | 0.00 | 0.00 | 0.00 |
Unsecured Loans | 0.00 | 0.00 | 0.99 |
Total Debt | 0.00 | 0.00 | 0.99 |
Total Liabilities | 19.04 | 21.62 | 0.13 |
Application of Funds | |||
Gross Block | 0.06 | 0.01 | 0.01 |
Capital Work in Progress | 0.00 | 0.00 | 0.00 |
Investments | 5.76 | 7.53 | 0.00 |
Current Assets, Loans & Advances | |||
Inventories | 0.00 | 0.00 | 0.00 |
Sundry Debtors | 7.03 | 0.04 | 0.00 |
Cash and Bank | 2.58 | 5.20 | 0.16 |
Loans and Advances | 9.34 | 8.86 | 0.00 |
Total Current Assets | 18.95 | 14.10 | 0.16 |
Current Liabilities and Provisions | |||
Current Liabilities | 5.58 | 0.02 | 0.02 |
Provisions | 0.15 | 0.00 | 0.01 |
Net Current Assets | 13.22 | 14.08 | 0.13 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | N/A | N/A | N/A |
Deferred Tax Liability | N/A | N/A | N/A |
Net Deferred Tax | N/A | N/A | N/A |
Other Assets | 0.00 | 0.00 | 0.00 |
Total Assets | 19.03 | 21.62 | 0.14 |
Quick Links for Generic Pharmasec:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices